Public Health Management of Humans at Risk

Rabies

Volumn , Issue , 2007, Pages 545-571

  Briggs, Deborah J ^a   Mahendra, B J ^b  

^a KANSAS STATE UNIVERSITY   (United States)

^b Mandya Rajiv Gandhi University of Medical Sciences   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882516263     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369366-2/50018-X     Document Type: Chapter

References (95)

1. APCRI Assessing the burden of rabies in India. WHO sponsored multi-centric rabies survey 2003, final report. Association for the Prevention of Rabies in India 2004, 101. http://www.apcri.org.
2. Arguin P.M., Krebs J.W., Mandel E., Guzi T., Childs J.E. Survey of rabies pre-exposure and post-exposure among missionary personnel stationed outside the United States. Journal of Tropical Medicine 2000, 7:10-14.
3. Arya S.C. Therapeutic failures with rabies vaccine and rabies immunoglobulin. Clinical Infectious Diseases 1999, 29:1605.
4. Belotto A.J. The Pan American Health Organization (PAHO) role in the control of rabies in Latin America. Developmental Biology 2004, 119:213-216.
5. Belotto A.J., Leanes L.F., Schneider M.C., Tamayo H., Correa E. Overview of rabies in the Americas. Virus Research 2005, 111:5-12.
6. Bernard K.W., Fishbein D.B. Pre-exposure rabies prophylaxis for travellers: are the benefits worth the cost?. Vaccine 1991, 9:833-836.
7. Bernard K.W., Fishbein D.B., Miller K.D., et al. Pre-exposure rabies immunization with human diploid cell vaccine: Decreased antibody responses in persons immunized in developing countries. American Journal of Tropical Medicine and Hygiene 1985, 34:633-647.
8. Bernard K.W., Mallonee J., Wright J.C., et al. Preexposure immunization with intradermal human diploid cell rabies vaccine. American Journal of Tropical Medicine and Hygiene 1987, 257:1059-1063.
9. Bjorvatn B., Gundersen S.G. Rabies exposure among Norwegian missionaries working abroad. Scandinavian Journal of Infectious Diseases 1980, 12:257-264.
10. Briggs D.J., Dreesen D.W., Nicolay U., et al. Purified chick embryo ell culture rabies vaccine: interchangeability with human diploid cell culture rabies vaccine and comparison of a one-dose versus two-dose post-exposure booster regimen for previously immunized persons. Vaccine 2000, 19:1055-1060.
11. Burridge M.J., Gaer G.M., Sumner J.W., Sussman O. Intradermal immunization with human diploid cell rabies vaccine. Journal of the American Medical Association 1982, 248:1611-1614.
12. Centers for Disease Control Human rabies - Kenya. Morbidity and Mortality Weekly Report 1983, 32:494-495.
13. Centers for Disease Control Human rabies prevention - United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report 1999, 48:1-21.
14. Centers for Disease Control Notice to readers: Manufacturer's recall of human rabies vaccine - April 2, 2004. Morbidity and Mortality Weekly Report 2004, 53:287-289.
15. Centers for Disease Control Compendium of animal rabies prevention and control, 2005. Morbidity and Mortality Weekly Report 2005, 54:1-8.
16. Chhabra M., Ichhpujani R.L., Tewari K.N., Lal S. Human rabies in Delhi. Indian Journal of Pediatrics 2004, 71:217-220. [16.3].
17. Chomel B.B. Rabies exposure and clinical disease in animals. Rabies: Guidelines for Medical Professionals 1999, 20-26. Veterinary Learning Systems, Trenton.
18. Chutivongse S., Wilde H. Postexposure rabies vaccination during pregnancy: experience with 21 patients. Vaccine 1989, 7:546-548.
19. Chutivongse S., Wilde H., Supich C., Baer G.M., Fishbein D.B. Postexposure prophylaxis for rabies with antiserum and intradermal vaccination. Lancet 1990, 335:896-898.
20. Chutivongse S., Wilde H., Benjavongkulchai M., Chomchey P., Punthawong S. Postexposure rabies vaccination during pregnancy: Effect on 202 women and their infants. Clinical Infectious Diseases 1995, 20:818-820.
21. Coleman P.G., Dye C. Immunization coverage required to prevent outbreaks of dog rabies. Vaccine 1996, 14:85-186.
22. Conomy J.P., Leibovitz A., McCombs W., Stinson J. Airborne rabies encephalitis: demonstration of rabies virus in the human central nervous system. Neurology 1977, 27:67-69.
23. Constantine D.G. Rabies transmission by nonbite route. Public Health Report 1962, 77:287-289.
24. Dean D.J., Baer G.M. Studies on the local treatment of rabies-infected wounds. Bulletin of the World Health Organization 1963, 28:477-486.
25. Deshpande A., Briggs D.J. Rabies vaccination in immunosuppressed patients. Rabies Control in Asia 2001, 58-60. [16.2], John Libby Eurotext, Paris. B. Dodet, F.-X. Meslin (Eds.).
26. Dreesen D.W., Bernard K.W., Parker R.A., Deutsch A.J., Brown J. Immune complex-like disease in 23 persons following a booster dose of rabies human diploid cell vaccine. Vaccine 1986, 4:45-49.
27. Dreesen D.W., Fishbein D.B., Kemp D.T., Brown J. Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization. Vaccine 1989, 7:397-400.
28. Fekadu M., Endeshaw T., Alemu W., Bogale Y., Teshager T., Olson J.G. Possible human-to-human transmission of rabies in Ethiopia. Ethiopian Medical Journal 1996, 34:123-127.
29. Fescharek R., Schwarz S., Quast U., Gandhi N., Karkhanis S. Postexposure rabies prophylaxis: when the guidelines are not respected. Vaccine 1991, 9:868-872.
30. Fevre E.M., Kayoyo R.W., Persson V., Edelsten M., Coleman P.G., Cleaveland S. The epidemiology of animal bite injuries in Uganda and projections of the burden of rabies. Tropical Medicine and International Health 2005, 10:790-798.
31. Fishbein D.B., Bernard K.W., Miller K.D., et al. The early kinetics of the neutralizing antibody response after booster immunizations with human diploid cell rabies vaccine. American Journal of Tropical Medicine and Hygiene 1986, 35:663-670.
32. Fishbein D.B., Yenne K.M., Dreesen D.W., Teplis C.F., Mehta N., Briggs D.J. Risk factors for systemic hypersensitivity reactions after booster vaccinations with human diploid cell rabies vaccine: a nationwide prospective study. Vaccine 1993, 11:1390-1394.
33. Fleisher G.R. The management of bite wounds. New England Journal of Medicine 1999, 340:138.
34. Fooks A.R., Johnson N., Brookes S.M., Parsons G., McElhinney L.M. Risk factors associated with travel to rabies endemic countries. Journal of Applied Microbiology 2003, 94:31S-36S.
35. Ghosh T.K. Controversies in rabies vaccination. Indian Journal of Pediatrics 2003, 70:495-498.
36. Hatchett R.P. Rabies: the disease and the value of intensive care treatment. Intensive Care Nursing 1991, 7:53-60.
37. Hatz C.F., Bidaus J.M., Eichenberger K., Mikulics U., Junghanss T. Circumstances and management of 72 animals bites among long-term residents in the tropics. Vaccine 1995, 13:811-815.
38. Hemachudha T., Mitrabhakdi E., Wilde H., Vejabhuti A., Siripataravanit S., Kingnate D. Additional reports of failure to respond to treatment after rabies exposure in Thailand. Clinical Infectious Diseases 1999, 28:143-144.
39. Jaiiaroensup W., Lanag J., Thipkong P., et al. Safety and efficacy of purified vero cell rabies vaccine given intramuscularly and intradermally. (Results of a prospective randomized trial.). Vaccine 1998, 16:1559-1562.
40. Javadi M.A., Fayaz A., Mirdehghan S.A., Ainollahi B. Transmission of rabies by corneal graft. Cornea 1996, 15:431-433.
41. Jones R.L., Froeschle J.E., Atmar R.L., et al. Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine. Vaccine 2001, 19:4635-4643.
42. Kamoltham T., Singhsa J., Promsaranee U., Sonthon P., Mathean P., Thinyounyong W. Elimination of human rabies in a canine endemic province in Thailand: five-year programme. Bulletin of the World Health Organization 2003, 81:375-381.
43. Kaplan M.M., Cohen D., Koprowski H., Dean D., Ferrigan L. Studies on the local treatment of wounds for the prevention of rabies. Bulletin of the World Health Organization 1962, 26:765-775.
44. Khawplod P., Wilde H., Chomchey P., et al. What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously?. Vaccine 1996, 14:389-391.
45. Knobel D.L., Cleaveland S., Coleman P.G., et al. Re-evaluating the burden of rabies in Africa and Asia. Bulletin of the World Health Organization 2005, 83:360-368.
46. Krause E., Grundmann H., Hatz C. Pretravel advice neglects rabies risk for travelers to tropical countries. Journal of Travel Medicine 1999, 6:163-167.
47. Krebs J.W., Mandel E.J., Rupprecht C.R. Rabies surveillance in the United States during 2003. Journal of the American Veterinary Medical Association 2004, 225:1837-1849.
48. Lang J., Simanjuntak G.H., Soerjosembodo S., Koesharyono C. Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. Bulletin of the World Health Organization 1998, 76:491-495. the MAS054 Clinical Investigator Group.
49. Lau J. Intradermal rabies vaccination and current use of mefloquine. Journal of Travel Medicine 1999, 6:140-141.
50. Mackell S.M. Vaccinations for the pediatric traveler. Clinical Infectious Diseases 2003, 37:1508-1516.
51. Madhusudana S.N., Anand N.P., Shamsundar R. Evaluation of two intradermal vaccination regimens using purified chick embryo cell vaccine for post-exposure prophylaxis of rabies. National Medical Journal of India 2001, 14:145-147.
52. Malerczyk C., Briggs D.J., Dreesen D.W., Banzhoff A. Duration of immunity: An anamnestic response 14 years after rabies vaccination with Purified Chick Embryo Cell Rabies Vaccine (PCECV). Journal of Travel Medicine 2007, 14:63-64.
53. Messenger S.L., Smith J.S., Rupprecht C.E. Emerging epidemiology of bat-associated cryptic cases of rabies in humans in the United States. Clinical Infectious Diseases 2002, 35:738-747.
54. Mondul A.M., Krebs J.W., Childs J.E. Trends in national surveillance for rabies among bats in the United States (1993-2000). Journal of the American Veterinary Medical Association 2003, 222:633-639.
55. Murray K.O., Arguin P.M. Decision-based evaluation of recommendations for preexposure rabies vaccination. Journal of the American Veterinary Medical Association 2000, 216:188-191.
56. Nathwani D., McIntyre P.G., White K., et al. Fatal human rabies caused by European bat Lyssavirus type 2a infection in Scotland. Clinical Infectious Diseases 2003, 37:598-601.
57. Noah D.L., Drenzek C.L., Smith J.S., et al. Epidemiology of human rabies in the United States, 1980 to 1996. Annals of Internal Medicine 1998, 128:922-929.
58. Pancharoen C., Thisyakorn U., Lawtongkum W., Wilde H. Rabies exposures in Thai children. Wildlife Environmental Medicine 2001, 12:239-243.
59. Pappaioanou M., Fishbeinn D.B., Dreesen D.W., et al. Antibody response to preexposure human diploid-cell rabies vaccine given concurrently with chloroquine. New England Journal of Medicine 1986, 314:280-284.
60. Parviz S., Chotani R., McCormick J., Fisher-Hoch S., Luby S. Rabies deaths in Pakistan: results of ineffective post-exposure treatment. International Journal of Infectious Diseases 2004, 8:346-352.
61. Peigue-Lafeuille H., Bourhy H., Abiteboul D., et al. Human rabies in France in 2004: update and management. Médécine et maladies infectieuses 2004, 34:551-560.
62. Phanuphak P., Ubolyam S., Sirivichayakul S. Should travellers in rabies endemic areas receive pre-exposure rabies immunization?. Annales de Médécine Interne (Paris) 1994, 145:167-176.
63. Prasad V.S., Duggal M., Aggarwal A.K., Kumar R. Animal bite management practices: A survey of health care providers in a community development block of Haryana. Journal of Communicable Diseases 2001, 44:266-273.
64. Quiambao B.P., Dimaano E.M., Ambas C., Davis R., Banzhoff A., Malerczyk C. Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals. Vaccine 2005, 25:1709-1714.
65. Reddy A.V., Sampath G. Post exposure treatment - some experiences. Journal of the Association for Prevention and Control of Rabies in India 2000, 1:33-35.
66. Remington P.A., Shope T., Andrews J. A recommended approach to the evaluation of human rabies exposure in an acute-care hospital. Journal of the American Medical Association 1985, 254:67-69.
67. Sabchareon A., Chantavanich P., Pasuralertsakul S., et al. Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine. Pediatric Infectious Diseases Journal 1998, 17:1001-1007.
68. Sampath G., Parikh S., Sangram P., Briggs D.J. Rabies post-exposure prophylaxis in malnourished children exposed to suspect rabid animals. Vaccine 2005, 23:1102-1105.
69. Shankar S.K., Madhusudana S.N., Satyanarayana S.H. Pathological morbidity following Semple type antirabies vaccine in India and why we need to replace it. Journal of the Association for Prevention and Control of Rabies in India 2000, 1:15-20.
70. Shill M., Baynes R.D., Miller S.D. Fatal rabies encephalitis despite appropriate post-exposure prophylaxis. New England Journal of Medicine 1987, 316:1257-1258.
71. Singh J., Jain D.C., Bhatia R., et al. Epidemiological characteristics of rabies in Delhi and surrounding areas, 1998. Indian Pediatrics 2001, 38:1354-1360.
72. Slate D., Rupprecht C.E., Rooney J.A., Donovan D., Lein D.H., Chipman R.B. Status of oral rabies vaccination in wild carnivores in the United States. Virus Research 2005, 111:68-76.
73. Smith J., McElhinney L., Parsons G., et al. Case report: rapid ante-mortem diagnosis of a human case of rabies imported from the Philippines. Journal of Medical Virology 2003, 69:150-155.
74. Sriaroon C., Daviratanasilpa S., Sansomranjai P., et al. Rabies in a Thai child treated with the eight-site post-exposure regimen without rabies immune globulin. Vaccine 2003, 21:3525-3526.
75. Srinivasan A., Burton E.C., Kuehnert M.J., et al. Transmission of rabies virus from an organ donor to four transplant recipients. New England Journal of Medicine 2005, 352:1103-1111.
76. Strady A., Lang J., Lienard M., Blondeau C., Jaussaud R., Plotkin S.A. Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy. Journal of Infectious Diseases 1998, 177:1290-1295.
77. Sudarshan M.K., Madhusudana S.N., Mahendra B.J. Post-exposure prophylaxis with purified Vero cell rabies vaccine during pregnancy-safety and immunogenicity. Journal of Communicable Diseases 1999, 31:229-236.
78. Swanson M.C., Rosanoff E., Gurwith M., Deitch M., Schnurrenberger P., Reed C.E. IgE and IgG antibodies to β-propiolactone and human serum albumin associated with urticarial reactions to rabies vaccine. Journal of Infectious Diseases 1987, 155:909-913.
79. Thisyakorn U., Pancharoen C., Ruxrungtham K., et al. Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1. Clinical Infectious Diseases 2000, 30:218.
80. Traenhart O., Kreuzfelder E., Hillebrandt M., et al. Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man. Clinical Immunology and Immunopathology 1994, 71:287-292.
81. Trevejo R.T. Rabies preexposure vaccination among veterinarians and at-risk staff. Journal of the American Veterinary Medical Association 2000, 217:1647-1650.
82. Trimarchi C.V., Briggs D.J. The diagnosis of rabies. Rabies: Guidelines for medical professionals 1999, 55-66. Veterinary Learning Systems, Trenton.
83. Varner M.W., McGuinness G.A. Rabies vaccination in pregnancy. American Journal of Obstetrics and Gynecology 1982, 143:717-718.
84. Vodopija R., Sureau P., Smerdel S., et al. Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment. Vaccine 1988, 6:283-286.
85. Wasi C., Chaiprasithikul P., Thongcharoen P., Choomkasien P., Sirikawin S. Progress and achievement of rabies control in Thailand. Vaccine 1997, 15:S7-S11.
86. WHO Report of a consultation on transfer of technology for production of rabies vaccine: January 16-17, 1986 1986, VPH/86.64, WHO, Geneva.
87. WHO Guidelines for dog rabies control 1987, VPH/83.43 Rev. 1, WHO, Geneva.
88. WHO World Health Organization expert committe on rabies. Eighth report. WHO. Technical Report Series 824, Geneva, WHO 1992.
89. WHO World Health Organization recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies 1996, WHO/EMC/ZOO96.6, WHO, Geneva.
90. WHO Intradermal application of rabies vaccines. Report of a WHO consultation, Bangkok, Thailand 5-6 June, 2000 2000, WHO/CDS/CDSRAPH/2000.05, WHO, Geneva.
91. WHO WHO Technical report series 931, Geneva, WHO 2005.
92. Wilde H. Economic issues in postexposure rabies treatment. Journal of Travel Medicine 1999, 6:238-242.
93. Wilde H., Briggs D.J., Meslin F.X., Hemachudha T., Sitprija V. Rabies update fortravel medicine advisors. Clinical Infectious Diseases 2003, 37:96-100.
94. Windiyaningsih C., Wilde H., Meslin F.X., Suroso T., Widarso H.S. The rabies epidemic on Flores Island, Indonesia (1998-2003). Journal of the Medical Association of Thailand 2004, 87:1-5.
95. Winkler W.G., Fashinell T.R., Leffingwell L., Howard P., Conomy J.P. Airborne rabies transmission in a laboratory worker. Journal of the American Medical Association 1973, 226:1219-1222.